Studies have reported that ROR1 is expressed at a high level in human leukemia and several solid malignancies3–5, suggesting that detection of ROR1 as a prognostic biomarker is important for the on time clinical analysis and the long-term treatment monitoring. Here, ROR1 is linked to leukemia.